Back to 
UBS Group AG
UBS Group AG
QNCX1 quarters
Position history for UBS Group AG's holdings in QUINCE THERAPEUTICS INC
Yes. Ubs holds 4,730 shares of QNCX (Quince Therapeutics), worth $86,039, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$86,039
Current Shares
4,730
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of QNCX: BALYASNY ASSET MANAGEMENT L.P., MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, MORGAN STANLEY